NeuroEM

NeuroEM Therapeutics is a medical device company pioneering a non-invasive, wearable technology designed to treat and potentially reverse cognitive decline in Alzheimer's disease. Their FDA-designated Breakthrough Device, the MemorEM™, delivers Transcranial Electromagnetic Treatment using Radio Frequencies (TEMT-RF) to target and disaggregate toxic protein aggregates (beta-amyloid and p-tau) within neurons, aiming to restore cognitive function and halt disease progression.